{"transactions":[{"id":4637321,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Ordinary Shares","published_at":"2026-10-07T21:44:28.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":236.4,"value":472800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on June 4, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":141394,"source":{"system":"sec-edgar","filing":"0001607737-26-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607737/000160773726000016/edgardoc.xml","form_type":"4"}},{"id":4630074,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-10-05T20:18:35.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":6000,"price":230.33,"value":1381980.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on November 26, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":345875,"source":{"system":"sec-edgar","filing":"0001193210-26-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000028/edgardoc.xml","form_type":"4"}},{"id":4617451,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32741,"kind":"person","name":"Patil Neena M","position":1,"cik":"0001783908","reported_name":"Patil Neena M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2026-09-14T22:38:04.000Z","date":"2026-09-10","kind":"sale","planned":true,"acquired":false,"shares":1200,"price":240.94,"value":289128.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on February 26, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":47671,"source":{"system":"sec-edgar","filing":"0001783908-26-000022","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1783908/000178390826000022/edgardoc.xml","form_type":"4"}},{"id":4614763,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Ordinary Shares","published_at":"2026-09-10T20:33:02.000Z","date":"2026-09-08","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":243.03,"value":486060.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a plan adopted by the reporting person on June 4, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":143394,"source":{"system":"sec-edgar","filing":"0001607737-26-000013","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607737/000160773726000013/edgardoc.xml","form_type":"4"}},{"id":4614762,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Ordinary Shares","published_at":"2026-09-10T20:33:02.000Z","date":"2026-09-08","kind":"tax_withholding","planned":true,"acquired":false,"shares":1967,"price":246.81,"value":485475.27,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":145394,"source":{"system":"sec-edgar","filing":"0001607737-26-000013","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607737/000160773726000013/edgardoc.xml","form_type":"4"}},{"id":4614685,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":926,"kind":"person","name":"Henderson Mary Elizabeth","position":1,"cik":"0001989533","reported_name":"Henderson Mary Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Ordinary Shares","published_at":"2026-09-10T20:28:55.000Z","date":"2026-09-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":15,"price":241.2,"value":3618.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":23815,"source":{"system":"sec-edgar","filing":"0001989533-26-000019","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1989533/000198953326000019/edgardoc.xml","form_type":"4"}},{"id":4614684,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":926,"kind":"person","name":"Henderson Mary Elizabeth","position":1,"cik":"0001989533","reported_name":"Henderson Mary Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Ordinary Shares","published_at":"2026-09-10T20:28:55.000Z","date":"2026-09-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":1412,"price":243.0299,"value":343158.2188,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":23830,"source":{"system":"sec-edgar","filing":"0001989533-26-000019","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1989533/000198953326000019/edgardoc.xml","form_type":"4"}},{"id":1085,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":926,"kind":"person","name":"Henderson Mary Elizabeth","position":1,"cik":"0001989533","reported_name":"Henderson Mary Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:38:13.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":16,"price":244.6444,"value":3914.3104,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":25242,"source":{"system":"sec-edgar","filing":"0001989533-26-000015","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1989533/000198953326000015/edgardoc.xml","form_type":"4"}},{"id":1084,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":926,"kind":"person","name":"Henderson Mary Elizabeth","position":1,"cik":"0001989533","reported_name":"Henderson Mary Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:38:13.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":2076,"price":241.39,"value":501125.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":25258,"source":{"system":"sec-edgar","filing":"0001989533-26-000015","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1989533/000198953326000015/edgardoc.xml","form_type":"4"}},{"id":1072,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:34:50.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":1692,"price":241.39,"value":408431.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":9579,"source":{"system":"sec-edgar","filing":"0001756253-26-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1756253/000175625326000009/edgardoc.xml","form_type":"4"}},{"id":1071,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:34:50.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":14,"price":244.6443,"value":3425.0202,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":11271,"source":{"system":"sec-edgar","filing":"0001756253-26-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756253/000175625326000009/edgardoc.xml","form_type":"4"}},{"id":1064,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":903,"kind":"person","name":"RIEDEL NORBERT G","position":1,"cik":"0001161662","reported_name":"RIEDEL NORBERT G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:31:14.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":1692,"price":241.39,"value":408431.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":6923,"source":{"system":"sec-edgar","filing":"0001161662-26-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000116166226000008/edgardoc.xml","form_type":"4"}},{"id":1063,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":903,"kind":"person","name":"RIEDEL NORBERT G","position":1,"cik":"0001161662","reported_name":"RIEDEL NORBERT G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:31:14.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":14,"price":244.6443,"value":3425.0202,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":8615,"source":{"system":"sec-edgar","filing":"0001161662-26-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000116166226000008/edgardoc.xml","form_type":"4"}},{"id":1051,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":893,"kind":"person","name":"LOVE TED W","position":1,"cik":"0001188919","reported_name":"LOVE TED W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:28:35.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":737,"price":241.3899,"value":177904.3563,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":2389,"source":{"system":"sec-edgar","filing":"0001188919-26-000015","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000118891926000015/edgardoc.xml","form_type":"4"}},{"id":1050,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":893,"kind":"person","name":"LOVE TED W","position":1,"cik":"0001188919","reported_name":"LOVE TED W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:28:35.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":6,"price":244.0633,"value":1464.3798,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":3126,"source":{"system":"sec-edgar","filing":"0001188919-26-000015","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000118891926000015/edgardoc.xml","form_type":"4"}},{"id":1037,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":874,"kind":"person","name":"Hamill Laura","position":1,"cik":"0001751804","reported_name":"Hamill Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:24:03.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":1692,"price":241.39,"value":408431.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":6832,"source":{"system":"sec-edgar","filing":"0001751804-26-000005","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1751804/000175180426000005/edgardoc.xml","form_type":"4"}},{"id":1036,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":874,"kind":"person","name":"Hamill Laura","position":1,"cik":"0001751804","reported_name":"Hamill Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:24:03.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":14,"price":244.0643,"value":3416.9002,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":8524,"source":{"system":"sec-edgar","filing":"0001751804-26-000005","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1751804/000175180426000005/edgardoc.xml","form_type":"4"}},{"id":1025,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:20:38.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":1692,"price":241.39,"value":408431.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":10736,"source":{"system":"sec-edgar","filing":"0001754371-26-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1754371/000175437126000007/edgardoc.xml","form_type":"4"}},{"id":1024,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:20:38.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":14,"price":244.0643,"value":3416.9002,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":12428,"source":{"system":"sec-edgar","filing":"0001754371-26-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1754371/000175437126000007/edgardoc.xml","form_type":"4"}},{"id":1012,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:17:08.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":1692,"price":241.39,"value":408431.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":21278,"source":{"system":"sec-edgar","filing":"0001253886-26-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000125388626000011/edgardoc.xml","form_type":"4"}},{"id":1011,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:17:08.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":14,"price":244.6443,"value":3425.0202,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":22970,"source":{"system":"sec-edgar","filing":"0001253886-26-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1253886/000125388626000011/edgardoc.xml","form_type":"4"}},{"id":1007,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":843,"kind":"person","name":"McSharry Heather Ann","position":1,"cik":"0001576068","reported_name":"McSharry Heather Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:13:50.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":1840,"price":241.39,"value":444157.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":18199,"source":{"system":"sec-edgar","filing":"0001576068-26-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576068/000157606826000009/edgardoc.xml","form_type":"4"}},{"id":1006,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":843,"kind":"person","name":"McSharry Heather Ann","position":1,"cik":"0001576068","reported_name":"McSharry Heather Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:13:50.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":15,"price":244.6447,"value":3669.6705,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":20039,"source":{"system":"sec-edgar","filing":"0001576068-26-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576068/000157606826000009/edgardoc.xml","form_type":"4"}},{"id":997,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":832,"kind":"person","name":"Kennedy Patrick","position":1,"cik":"0002013944","reported_name":"Kennedy Patrick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:09:50.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":1840,"price":241.39,"value":444157.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":6452,"source":{"system":"sec-edgar","filing":"0002013944-26-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2013944/000201394426000006/edgardoc.xml","form_type":"4"}},{"id":996,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":832,"kind":"person","name":"Kennedy Patrick","position":1,"cik":"0002013944","reported_name":"Kennedy Patrick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:09:50.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":15,"price":244.0647,"value":3660.9705,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":8292,"source":{"system":"sec-edgar","filing":"0002013944-26-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2013944/000201394426000006/edgardoc.xml","form_type":"4"}},{"id":953,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:06:45.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":14,"price":244.6443,"value":3425.0202,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":9466,"source":{"system":"sec-edgar","filing":"0001302443-26-000015","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000130244326000015/edgardoc.xml","form_type":"4"}},{"id":952,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:06:45.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":1692,"price":241.39,"value":408431.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":9480,"source":{"system":"sec-edgar","filing":"0001302443-26-000015","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302443/000130244326000015/edgardoc.xml","form_type":"4"}},{"id":942,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:03:36.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":6000,"price":250.13,"value":1500780.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was made pursuant to a plan adopted by the reporting person on November 26, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":351875,"source":{"system":"sec-edgar","filing":"0001193210-26-000025","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000025/edgardoc.xml","form_type":"4"}},{"id":941,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:03:36.000Z","date":"2026-08-31","kind":"tax_withholding","planned":true,"acquired":false,"shares":1209,"price":241.3899,"value":291840.3891,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":357875,"source":{"system":"sec-edgar","filing":"0001193210-26-000025","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000025/edgardoc.xml","form_type":"4"}},{"id":940,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:03:36.000Z","date":"2026-08-31","kind":"tax_withholding","planned":true,"acquired":false,"shares":10,"price":244.064,"value":2440.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the November 3, 2025 disposition of 3,193 shares for the withholding of restricted stock units by the Issuer to satisfy FICA taxes arising from the Reporting Person being retirement eligible which was previously inadvertently not reported; not an open market transaction."}],"balance_after":359084,"source":{"system":"sec-edgar","filing":"0001193210-26-000025","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000025/edgardoc.xml","form_type":"4"}},{"id":672038,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":18427,"kind":"person","name":"Iannone Robert","position":1,"cik":"0001737329","reported_name":"Iannone Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Head of R&D & CMO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-08-31T22:45:25.000Z","date":"2026-08-27","kind":"exercise","planned":true,"acquired":false,"shares":27584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on May 28, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of May 29, 2019, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":137.12,"expiration_date":"2029-08-07","underlying":"Ordinary Shares","underlying_shares":27584},"source":{"system":"sec-edgar","filing":"0001737329-26-000016","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1737329/000173732926000016/edgardoc.xml","form_type":"4"}},{"id":672037,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":18427,"kind":"person","name":"Iannone Robert","position":1,"cik":"0001737329","reported_name":"Iannone Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Head of R&D & CMO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-08-31T22:45:25.000Z","date":"2026-08-27","kind":"exercise","planned":true,"acquired":false,"shares":26116,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on May 28, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 27, 2020, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":113.1,"expiration_date":"2030-02-26","underlying":"Ordinary Shares","underlying_shares":26116},"source":{"system":"sec-edgar","filing":"0001737329-26-000016","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1737329/000173732926000016/edgardoc.xml","form_type":"4"}},{"id":672036,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":18427,"kind":"person","name":"Iannone Robert","position":1,"cik":"0001737329","reported_name":"Iannone Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Head of R&D & CMO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2026-08-31T22:45:25.000Z","date":"2026-08-27","kind":"exercise","planned":true,"acquired":false,"shares":2916,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on May 28, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of May 29, 2019, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":137.12,"expiration_date":"2029-08-07","underlying":"Ordinary Shares","underlying_shares":2916},"source":{"system":"sec-edgar","filing":"0001737329-26-000016","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1737329/000173732926000016/edgardoc.xml","form_type":"4"}},{"id":672035,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":18427,"kind":"person","name":"Iannone Robert","position":1,"cik":"0001737329","reported_name":"Iannone Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Head of R&D & CMO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2026-08-31T22:45:25.000Z","date":"2026-08-27","kind":"exercise","planned":true,"acquired":false,"shares":884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on May 28, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 27, 2020, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":113.1,"expiration_date":"2030-02-26","underlying":"Ordinary Shares","underlying_shares":884},"source":{"system":"sec-edgar","filing":"0001737329-26-000016","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1737329/000173732926000016/edgardoc.xml","form_type":"4"}},{"id":672034,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":18427,"kind":"person","name":"Iannone Robert","position":1,"cik":"0001737329","reported_name":"Iannone Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Head of R&D & CMO"}}],"security":"Ordinary Shares","published_at":"2026-08-31T22:45:25.000Z","date":"2026-08-27","kind":"sale","planned":true,"acquired":false,"shares":300,"price":252.76,"value":75828.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on May 28, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":65686,"source":{"system":"sec-edgar","filing":"0001737329-26-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1737329/000173732926000016/edgardoc.xml","form_type":"4"}},{"id":672033,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":18427,"kind":"person","name":"Iannone Robert","position":1,"cik":"0001737329","reported_name":"Iannone Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Head of R&D & CMO"}}],"security":"Ordinary Shares","published_at":"2026-08-31T22:45:25.000Z","date":"2026-08-27","kind":"sale","planned":true,"acquired":false,"shares":9259,"price":251.9499,"value":2332804.1241,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on May 28, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $251.37 to $252.31. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":65986,"source":{"system":"sec-edgar","filing":"0001737329-26-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1737329/000173732926000016/edgardoc.xml","form_type":"4"}},{"id":672032,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":18427,"kind":"person","name":"Iannone Robert","position":1,"cik":"0001737329","reported_name":"Iannone Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Head of R&D & CMO"}}],"security":"Ordinary Shares","published_at":"2026-08-31T22:45:25.000Z","date":"2026-08-27","kind":"sale","planned":true,"acquired":false,"shares":19639,"price":250.6032,"value":4921596.2448,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on May 28, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $250.33 to $251.29. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":75245,"source":{"system":"sec-edgar","filing":"0001737329-26-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1737329/000173732926000016/edgardoc.xml","form_type":"4"}},{"id":672031,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":18427,"kind":"person","name":"Iannone Robert","position":1,"cik":"0001737329","reported_name":"Iannone Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Head of R&D & CMO"}}],"security":"Ordinary Shares","published_at":"2026-08-31T22:45:25.000Z","date":"2026-08-27","kind":"sale","planned":true,"acquired":false,"shares":18113,"price":250.0178,"value":4528572.4114,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on May 28, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $249.33 to $250.325 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":94884,"source":{"system":"sec-edgar","filing":"0001737329-26-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1737329/000173732926000016/edgardoc.xml","form_type":"4"}},{"id":672030,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":18427,"kind":"person","name":"Iannone Robert","position":1,"cik":"0001737329","reported_name":"Iannone Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Head of R&D & CMO"}}],"security":"Ordinary Shares","published_at":"2026-08-31T22:45:25.000Z","date":"2026-08-27","kind":"sale","planned":true,"acquired":false,"shares":11423,"price":248.6664,"value":2840516.2872,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on May 28, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $248.29 to $249.24. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":112997,"source":{"system":"sec-edgar","filing":"0001737329-26-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1737329/000173732926000016/edgardoc.xml","form_type":"4"}},{"id":672029,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":18427,"kind":"person","name":"Iannone Robert","position":1,"cik":"0001737329","reported_name":"Iannone Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Head of R&D & CMO"}}],"security":"Ordinary Shares","published_at":"2026-08-31T22:45:25.000Z","date":"2026-08-27","kind":"sale","planned":true,"acquired":false,"shares":18187,"price":247.8573,"value":4507780.7151,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on May 28, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $247.29 to $248.24. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":124420,"source":{"system":"sec-edgar","filing":"0001737329-26-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1737329/000173732926000016/edgardoc.xml","form_type":"4"}},{"id":672028,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":18427,"kind":"person","name":"Iannone Robert","position":1,"cik":"0001737329","reported_name":"Iannone Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Head of R&D & CMO"}}],"security":"Ordinary Shares","published_at":"2026-08-31T22:45:25.000Z","date":"2026-08-27","kind":"exercise","planned":true,"acquired":true,"shares":2916,"price":137.12,"value":399841.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on May 28, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":142607,"source":{"system":"sec-edgar","filing":"0001737329-26-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1737329/000173732926000016/edgardoc.xml","form_type":"4"}},{"id":672027,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":18427,"kind":"person","name":"Iannone Robert","position":1,"cik":"0001737329","reported_name":"Iannone Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Head of R&D & CMO"}}],"security":"Ordinary Shares","published_at":"2026-08-31T22:45:25.000Z","date":"2026-08-27","kind":"exercise","planned":true,"acquired":true,"shares":27584,"price":137.12,"value":3782318.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on May 28, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":139691,"source":{"system":"sec-edgar","filing":"0001737329-26-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1737329/000173732926000016/edgardoc.xml","form_type":"4"}},{"id":672026,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":18427,"kind":"person","name":"Iannone Robert","position":1,"cik":"0001737329","reported_name":"Iannone Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Head of R&D & CMO"}}],"security":"Ordinary Shares","published_at":"2026-08-31T22:45:25.000Z","date":"2026-08-27","kind":"exercise","planned":true,"acquired":true,"shares":884,"price":113.1,"value":99980.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on May 28, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":112107,"source":{"system":"sec-edgar","filing":"0001737329-26-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1737329/000173732926000016/edgardoc.xml","form_type":"4"}},{"id":672025,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":18427,"kind":"person","name":"Iannone Robert","position":1,"cik":"0001737329","reported_name":"Iannone Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Head of R&D & CMO"}}],"security":"Ordinary Shares","published_at":"2026-08-31T22:45:25.000Z","date":"2026-08-27","kind":"exercise","planned":true,"acquired":true,"shares":26116,"price":113.1,"value":2953719.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on May 28, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":111223,"source":{"system":"sec-edgar","filing":"0001737329-26-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737329/000173732926000016/edgardoc.xml","form_type":"4"}},{"id":693552,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2026-08-07T22:01:08.000Z","date":"2026-08-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":780,"price":261.62,"value":204063.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":47131,"source":{"system":"sec-edgar","filing":"0001805688-26-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000180568826000014/edgardoc.xml","form_type":"4"}},{"id":692948,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-07T21:57:14.000Z","date":"2026-08-05","kind":"grant","planned":false,"acquired":true,"shares":1605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027."}],"balance_after":11172,"source":{"system":"sec-edgar","filing":"0001302443-26-000010","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000130244326000010/edgardoc.xml","form_type":"4"}},{"id":692947,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":893,"kind":"person","name":"LOVE TED W","position":1,"cik":"0001188919","reported_name":"LOVE TED W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-07T21:55:11.000Z","date":"2026-08-05","kind":"grant","planned":false,"acquired":true,"shares":1605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027."}],"balance_after":3132,"source":{"system":"sec-edgar","filing":"0001188919-26-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000118891926000012/edgardoc.xml","form_type":"4"}},{"id":692946,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":874,"kind":"person","name":"Hamill Laura","position":1,"cik":"0001751804","reported_name":"Hamill Laura","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-07T21:50:57.000Z","date":"2026-08-05","kind":"grant","planned":false,"acquired":true,"shares":1605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027."}],"balance_after":8538,"source":{"system":"sec-edgar","filing":"0001751804-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000175180426000002/edgardoc.xml","form_type":"4"}},{"id":693293,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":832,"kind":"person","name":"Kennedy Patrick","position":1,"cik":"0002013944","reported_name":"Kennedy Patrick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-07T21:48:22.000Z","date":"2026-08-05","kind":"grant","planned":false,"acquired":true,"shares":1605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027."}],"balance_after":8307,"source":{"system":"sec-edgar","filing":"0002013944-26-000003","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2013944/000201394426000003/edgardoc.xml","form_type":"4"}},{"id":692945,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-07T21:46:06.000Z","date":"2026-08-05","kind":"grant","planned":false,"acquired":true,"shares":1605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027."}],"balance_after":11285,"source":{"system":"sec-edgar","filing":"0001756253-26-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000175625326000006/edgardoc.xml","form_type":"4"}},{"id":692944,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":861,"kind":"person","name":"Cook Jennifer E.","position":1,"cik":"0001754371","reported_name":"Cook Jennifer E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-07T21:44:10.000Z","date":"2026-08-05","kind":"grant","planned":false,"acquired":true,"shares":1605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027."}],"balance_after":12442,"source":{"system":"sec-edgar","filing":"0001754371-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000175437126000004/edgardoc.xml","form_type":"4"}},{"id":692943,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-07T21:42:20.000Z","date":"2026-08-05","kind":"grant","planned":false,"acquired":true,"shares":1605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027."}],"balance_after":1184633,"source":{"system":"sec-edgar","filing":"0001536639-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000153663926000004/edgardoc.xml","form_type":"4"}},{"id":693042,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":843,"kind":"person","name":"McSharry Heather Ann","position":1,"cik":"0001576068","reported_name":"McSharry Heather Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-07T21:39:14.000Z","date":"2026-08-05","kind":"grant","planned":false,"acquired":true,"shares":1605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027."}],"balance_after":20054,"source":{"system":"sec-edgar","filing":"0001576068-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576068/000157606826000004/edgardoc.xml","form_type":"4"}},{"id":692942,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":847,"kind":"person","name":"ENRIGHT PATRICK G","position":1,"cik":"0001253886","reported_name":"ENRIGHT PATRICK G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-07T21:37:03.000Z","date":"2026-08-05","kind":"grant","planned":false,"acquired":true,"shares":1605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027."}],"balance_after":22984,"source":{"system":"sec-edgar","filing":"0001253886-26-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000125388626000008/edgardoc.xml","form_type":"4"}},{"id":693357,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":903,"kind":"person","name":"RIEDEL NORBERT G","position":1,"cik":"0001161662","reported_name":"RIEDEL NORBERT G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-07T21:33:47.000Z","date":"2026-08-05","kind":"grant","planned":false,"acquired":true,"shares":1605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares beneficially owned by NORBERT G. RIEDEL 2023 TRUST, an entity owned and controlled by the reporting person and his immediate family."}],"balance_after":8629,"source":{"system":"sec-edgar","filing":"0001161662-26-000005","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1161662/000116166226000005/edgardoc.xml","form_type":"4"}},{"id":692941,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-07T21:31:54.000Z","date":"2026-08-05","kind":"grant","planned":false,"acquired":true,"shares":1605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027."}],"balance_after":362287,"source":{"system":"sec-edgar","filing":"0001193210-26-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000020/edgardoc.xml","form_type":"4"}},{"id":695444,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-05T20:33:08.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":6000,"price":252.98,"value":1517880.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on November 26, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":360682,"source":{"system":"sec-edgar","filing":"0001193210-26-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000018/edgardoc.xml","form_type":"4"}},{"id":714859,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-07-06T22:23:03.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":6000,"price":240.47,"value":1442820.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on November 26, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":366682,"source":{"system":"sec-edgar","filing":"0001193210-26-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000016/edgardoc.xml","form_type":"4"}},{"id":719587,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2026-07-02T22:27:58.000Z","date":"2026-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":2527,"price":237.72,"value":600718.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 29, 2026."}],"balance_after":47911,"source":{"system":"sec-edgar","filing":"0001805688-26-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000180568826000012/edgardoc.xml","form_type":"4"}},{"id":717581,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Ordinary Shares","published_at":"2026-07-02T22:21:34.000Z","date":"2026-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":4835,"price":237.72,"value":1149376.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":147361,"source":{"system":"sec-edgar","filing":"0001607737-26-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000160773726000011/edgardoc.xml","form_type":"4"}},{"id":718087,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":18427,"kind":"person","name":"Iannone Robert","position":1,"cik":"0001737329","reported_name":"Iannone Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Head of R&D & CMO"}}],"security":"Ordinary Shares","published_at":"2026-07-02T22:16:53.000Z","date":"2026-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":3764,"price":237.72,"value":894778.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":85107,"source":{"system":"sec-edgar","filing":"0001737329-26-000010","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737329/000173732926000010/edgardoc.xml","form_type":"4"}},{"id":717580,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32741,"kind":"person","name":"Patil Neena M","position":1,"cik":"0001783908","reported_name":"Patil Neena M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2026-07-02T22:09:40.000Z","date":"2026-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":2678,"price":237.72,"value":636614.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":48871,"source":{"system":"sec-edgar","filing":"0001783908-26-000019","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000178390826000019/edgardoc.xml","form_type":"4"}},{"id":718534,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":33016,"kind":"person","name":"Johnson Philip L","position":1,"cik":"0002013156","reported_name":"Johnson Philip L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-07-02T22:04:57.000Z","date":"2026-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":3343,"price":237.72,"value":794697.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 29, 2026."}],"balance_after":56431,"source":{"system":"sec-edgar","filing":"0002013156-26-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2013156/000201315626000007/edgardoc.xml","form_type":"4"}},{"id":733764,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":914,"kind":"person","name":"Smith Mark Douglas","position":1,"cik":"0001756253","reported_name":"Smith Mark Douglas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-17T20:45:12.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":1157,"price":230.55,"value":266746.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on March 9, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":9680,"source":{"system":"sec-edgar","filing":"0001756253-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000175625326000004/edgardoc.xml","form_type":"4"}},{"id":739484,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32741,"kind":"person","name":"Patil Neena M","position":1,"cik":"0001783908","reported_name":"Patil Neena M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2026-06-12T20:14:37.000Z","date":"2026-06-10","kind":"sale","planned":true,"acquired":false,"shares":1200,"price":231.83,"value":278196.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on February 26, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person acquired 123 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 29, 2026."}],"balance_after":51549,"source":{"system":"sec-edgar","filing":"0001783908-26-000017","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000178390826000017/edgardoc.xml","form_type":"4"}},{"id":747709,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Ordinary Shares","published_at":"2026-06-05T20:40:45.000Z","date":"2026-06-03","kind":"gift","planned":false,"acquired":false,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were donated to The Gala Family Fund, a donor-advised fund."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 29, 2026."}],"balance_after":152196,"source":{"system":"sec-edgar","filing":"0001607737-26-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000160773726000008/edgardoc.xml","form_type":"4"}},{"id":751307,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-03T21:09:45.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":6000,"price":235.12,"value":1410720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on November 26, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":372682,"source":{"system":"sec-edgar","filing":"0001193210-26-000013","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000013/edgardoc.xml","form_type":"4"}},{"id":756851,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32741,"kind":"person","name":"Patil Neena M","position":1,"cik":"0001783908","reported_name":"Patil Neena M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2026-06-01T20:09:43.000Z","date":"2026-05-28","kind":"sale","planned":true,"acquired":false,"shares":1192,"price":236.97,"value":282468.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on February 26, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":52626,"source":{"system":"sec-edgar","filing":"0001783908-26-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000178390826000014/edgardoc.xml","form_type":"4"}},{"id":757887,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-06-01T20:06:22.000Z","date":"2026-05-28","kind":"exercise","planned":false,"acquired":false,"shares":6907,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of March 2, 2020,  1/4th vested on the first anniversary of the vesting commencement date and the remainder vested in 36 equal monthly installments thereafter. The option was fully vested as of March 2, 2024."}],"balance_after":0,"derivative":{"exercise_price":109.45,"expiration_date":"2030-05-06","underlying":"Ordinary Shares","underlying_shares":6907},"source":{"system":"sec-edgar","filing":"0001805688-26-000008","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000180568826000008/edgardoc.xml","form_type":"4"}},{"id":757886,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2026-06-01T20:06:22.000Z","date":"2026-05-28","kind":"sale","planned":false,"acquired":false,"shares":6907,"price":235.41,"value":1625976.87,"ownership":{"direct":true},"balance_after":50272,"source":{"system":"sec-edgar","filing":"0001805688-26-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000180568826000008/edgardoc.xml","form_type":"4"}},{"id":757885,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2026-06-01T20:06:22.000Z","date":"2026-05-28","kind":"exercise","planned":false,"acquired":true,"shares":6907,"price":109.45,"value":755971.15,"ownership":{"direct":true},"balance_after":57179,"source":{"system":"sec-edgar","filing":"0001805688-26-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000180568826000008/edgardoc.xml","form_type":"4"}},{"id":756850,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-06-01T20:01:41.000Z","date":"2026-05-28","kind":"exercise","planned":false,"acquired":false,"shares":3415,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This non-qualified stock option was granted on August 11, 2016 and vested over the period from September 1, 2016 through August 1, 2017. The options were fully vested as of August 1, 2017."}],"balance_after":0,"derivative":{"exercise_price":138.08,"expiration_date":"2026-08-10","underlying":"Ordinary Shares","underlying_shares":3415},"source":{"system":"sec-edgar","filing":"0001536639-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000153663926000002/edgardoc.xml","form_type":"4"}},{"id":756849,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25402,"kind":"person","name":"Mulligan Seamus","position":1,"cik":"0001536639","reported_name":"Mulligan Seamus","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-01T20:01:41.000Z","date":"2026-05-28","kind":"exercise","planned":false,"acquired":true,"shares":3415,"price":138.08,"value":471543.2,"ownership":{"direct":true},"balance_after":1183028,"source":{"system":"sec-edgar","filing":"0001536639-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000153663926000002/edgardoc.xml","form_type":"4"}},{"id":761539,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-05-27T22:13:08.000Z","date":"2026-05-22","kind":"exercise","planned":false,"acquired":false,"shares":3415,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This non-qualified stock option was granted on August 11, 2016 and vested over a period of one year from September 1, 2016. The options were fully vested as of August 1, 2017."}],"balance_after":0,"derivative":{"exercise_price":138.08,"expiration_date":"2026-08-10","underlying":"Ordinary Shares","underlying_shares":3415},"source":{"system":"sec-edgar","filing":"0001302443-26-000008","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000130244326000008/edgardoc.xml","form_type":"4"}},{"id":761538,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-05-27T22:13:08.000Z","date":"2026-05-22","kind":"sale","planned":false,"acquired":false,"shares":2741,"price":241.57,"value":662143.37,"ownership":{"direct":true},"balance_after":9567,"source":{"system":"sec-edgar","filing":"0001302443-26-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000130244326000008/edgardoc.xml","form_type":"4"}},{"id":761537,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":824,"kind":"person","name":"Winningham Rick E","position":1,"cik":"0001302443","reported_name":"Winningham Rick E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-05-27T22:13:08.000Z","date":"2026-05-22","kind":"exercise","planned":false,"acquired":true,"shares":3415,"price":138.08,"value":471543.2,"ownership":{"direct":true},"balance_after":12308,"source":{"system":"sec-edgar","filing":"0001302443-26-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000130244326000008/edgardoc.xml","form_type":"4"}},{"id":761736,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":843,"kind":"person","name":"McSharry Heather Ann","position":1,"cik":"0001576068","reported_name":"McSharry Heather Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-05-27T22:07:06.000Z","date":"2026-05-22","kind":"sale","planned":false,"acquired":false,"shares":2000,"price":241,"value":482000.0,"ownership":{"direct":true},"balance_after":18449,"source":{"system":"sec-edgar","filing":"0001576068-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576068/000157606826000002/edgardoc.xml","form_type":"4"}},{"id":791457,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-05-05T20:27:21.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":6000,"price":203.33,"value":1219980.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on November 26, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":378682,"source":{"system":"sec-edgar","filing":"0001193210-26-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000011/edgardoc.xml","form_type":"4"}},{"id":815974,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-04-03T21:09:49.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":24,"price":191.7447,"value":4601.8728,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on November 26, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":384682,"source":{"system":"sec-edgar","filing":"0001193210-26-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000009/edgardoc.xml","form_type":"4"}},{"id":815973,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-04-03T21:09:49.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":2292,"price":190.9383,"value":437630.5836,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on November 26, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $190.6051 to $190.5982. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":384706,"source":{"system":"sec-edgar","filing":"0001193210-26-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000009/edgardoc.xml","form_type":"4"}},{"id":815972,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-04-03T21:09:49.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":3684,"price":190.222,"value":700777.848,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on November 26, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $189.60 to $190.5603. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":386998,"source":{"system":"sec-edgar","filing":"0001193210-26-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000009/edgardoc.xml","form_type":"4"}},{"id":853302,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-03-09T21:31:30.000Z","date":"2026-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":15114,"price":188.69,"value":2851860.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":390682,"source":{"system":"sec-edgar","filing":"0001193210-26-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000007/edgardoc.xml","form_type":"4"}},{"id":853876,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":33016,"kind":"person","name":"Johnson Philip L","position":1,"cik":"0002013156","reported_name":"Johnson Philip L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-09T21:27:30.000Z","date":"2026-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":2615,"price":188.69,"value":493424.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":59608,"source":{"system":"sec-edgar","filing":"0002013156-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2013156/000201315626000004/edgardoc.xml","form_type":"4"}},{"id":853301,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":926,"kind":"person","name":"Henderson Mary Elizabeth","position":1,"cik":"0001989533","reported_name":"Henderson Mary Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Ordinary Shares","published_at":"2026-03-09T21:25:19.000Z","date":"2026-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":1394,"price":186.747,"value":260325.318,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $186.1633 to $186.7558. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":27334,"source":{"system":"sec-edgar","filing":"0001989533-26-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000198953326000011/edgardoc.xml","form_type":"4"}},{"id":854722,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-09T21:23:15.000Z","date":"2026-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":2503,"price":188.69,"value":472291.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":50272,"source":{"system":"sec-edgar","filing":"0001805688-26-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000180568826000006/edgardoc.xml","form_type":"4"}},{"id":853580,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":18427,"kind":"person","name":"Iannone Robert","position":1,"cik":"0001737329","reported_name":"Iannone Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Head of R&D & CMO"}}],"security":"Ordinary Shares","published_at":"2026-03-09T21:21:04.000Z","date":"2026-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":6209,"price":188.69,"value":1171576.21,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":88871,"source":{"system":"sec-edgar","filing":"0001737329-26-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737329/000173732926000006/edgardoc.xml","form_type":"4"}},{"id":853300,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-09T21:15:52.000Z","date":"2026-03-09","kind":"sale","planned":false,"acquired":false,"shares":1287,"price":182.94,"value":235443.78,"ownership":{"direct":true},"balance_after":6512,"source":{"system":"sec-edgar","filing":"0001784606-26-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000178460626000012/edgardoc.xml","form_type":"4"}},{"id":853299,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-09T21:15:52.000Z","date":"2026-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":1436,"price":186.7723,"value":268205.0228,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $186.06 to $186.9115. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":7799,"source":{"system":"sec-edgar","filing":"0001784606-26-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000178460626000012/edgardoc.xml","form_type":"4"}},{"id":853298,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32742,"kind":"person","name":"GALA RENEE D","position":1,"cik":"0001607737","reported_name":"GALA RENEE D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Ordinary Shares","published_at":"2026-03-09T21:10:12.000Z","date":"2026-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":7065,"price":188.69,"value":1333094.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":152630,"source":{"system":"sec-edgar","filing":"0001607737-26-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000160773726000006/edgardoc.xml","form_type":"4"}},{"id":853297,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":32741,"kind":"person","name":"Patil Neena M","position":1,"cik":"0001783908","reported_name":"Patil Neena M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Legal Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-09T21:07:22.000Z","date":"2026-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":5000,"price":188.69,"value":943450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":53818,"source":{"system":"sec-edgar","filing":"0001783908-26-000010","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000178390826000010/edgardoc.xml","form_type":"4"}},{"id":861073,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-03-04T21:24:46.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":233,"price":187.8444,"value":43767.7452,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $187.7783 to $188.1678 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":405796,"source":{"system":"sec-edgar","filing":"0001193210-26-000005","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000005/edgardoc.xml","form_type":"4"}},{"id":861072,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-03-04T21:24:46.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":2608,"price":186.734,"value":487002.272,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $186.500 to $187.4693. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":406029,"source":{"system":"sec-edgar","filing":"0001193210-26-000005","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000005/edgardoc.xml","form_type":"4"}},{"id":861071,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-03-04T21:24:46.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":3159,"price":186.0853,"value":587843.4627,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $185.500 to $186.4207. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":408637,"source":{"system":"sec-edgar","filing":"0001193210-26-000005","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000005/edgardoc.xml","form_type":"4"}},{"id":874920,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":903,"kind":"person","name":"RIEDEL NORBERT G","position":1,"cik":"0001161662","reported_name":"RIEDEL NORBERT G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-03-02T22:36:59.000Z","date":"2026-02-27","kind":"exercise","planned":false,"acquired":false,"shares":3415,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This non-qualified stock option was granted on August 11, 2016 and vested over a period of one year from September 1, 2016. The options were fully vested as of August 1, 2017."}],"balance_after":0,"derivative":{"exercise_price":138.08,"expiration_date":"2026-08-10","underlying":"Ordinary Shares","underlying_shares":3415},"source":{"system":"sec-edgar","filing":"0001161662-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1161662/000116166226000002/edgardoc.xml","form_type":"4"}},{"id":874919,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":903,"kind":"person","name":"RIEDEL NORBERT G","position":1,"cik":"0001161662","reported_name":"RIEDEL NORBERT G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-03-02T22:36:59.000Z","date":"2026-02-27","kind":"sale","planned":false,"acquired":false,"shares":3415,"price":192,"value":655680.0,"ownership":{"direct":true},"balance_after":7024,"source":{"system":"sec-edgar","filing":"0001161662-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1161662/000116166226000002/edgardoc.xml","form_type":"4"}},{"id":874918,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":903,"kind":"person","name":"RIEDEL NORBERT G","position":1,"cik":"0001161662","reported_name":"RIEDEL NORBERT G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-03-02T22:36:59.000Z","date":"2026-02-27","kind":"exercise","planned":false,"acquired":true,"shares":3415,"price":138.08,"value":471543.2,"ownership":{"direct":true},"balance_after":10439,"source":{"system":"sec-edgar","filing":"0001161662-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1161662/000116166226000002/edgardoc.xml","form_type":"4"}},{"id":874696,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":33016,"kind":"person","name":"Johnson Philip L","position":1,"cik":"0002013156","reported_name":"Johnson Philip L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-02T22:22:03.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":11857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2026, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person acquired 166 ordinary shares on May 30, 2025 and 140 shares on November 28, 2025 under a Section 423 Employee Stock Purchase Plan."}],"balance_after":62223,"source":{"system":"sec-edgar","filing":"0002013156-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2013156/000201315626000002/edgardoc.xml","form_type":"4"}},{"id":875462,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-02T22:19:00.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":9782,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2026, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":52775,"source":{"system":"sec-edgar","filing":"0001805688-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000180568826000004/edgardoc.xml","form_type":"4"}},{"id":874289,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":18427,"kind":"person","name":"Iannone Robert","position":1,"cik":"0001737329","reported_name":"Iannone Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Head of R&D & CMO"}}],"security":"Ordinary Shares","published_at":"2026-03-02T22:16:13.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":14822,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2026, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":95080,"source":{"system":"sec-edgar","filing":"0001737329-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1737329/000173732926000004/edgardoc.xml","form_type":"4"}},{"id":873791,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":62000,"kind":"person","name":"Carr Patricia","position":1,"cik":"0001784606","reported_name":"Carr Patricia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Accounting Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-02T22:14:13.000Z","date":"2026-02-27","kind":"sale","planned":false,"acquired":false,"shares":1117,"price":190.9073,"value":213243.4541,"ownership":{"direct":true},"balance_after":9235,"source":{"system":"sec-edgar","filing":"0001784606-26-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000178460626000007/edgardoc.xml","form_type":"4"}}],"next_cursor":"2026-03-02T22:14:13.000000Z,873791"}